Measles Virus Bearing Measles Inclusion Body Encephalitis-Derived Fusion Protein Is Pathogenic after Infection via the Respiratory Route.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
15 04 2019
Historique:
received: 29 10 2018
accepted: 30 01 2019
pubmed: 8 2 2019
medline: 29 1 2020
entrez: 8 2 2019
Statut: epublish

Résumé

A clinical isolate of measles virus (MeV) bearing a single amino acid alteration in the viral fusion protein (F; L454W) was previously identified in two patients with lethal sequelae of MeV central nervous system (CNS) infection. The mutation dysregulated the viral fusion machinery so that the mutated F protein mediated cell fusion in the absence of known MeV cellular receptors. While this virus could feasibly have arisen via intrahost evolution of the wild-type (wt) virus, it was recently shown that the same mutation emerged under the selective pressure of small-molecule antiviral treatment. Under these conditions, a potentially neuropathogenic variant emerged outside the CNS. While CNS adaptation of MeV was thought to generate viruses that are less fit for interhost spread, we show that two animal models can be readily infected with CNS-adapted MeV via the respiratory route. Despite bearing a fusion protein that is less stable at 37°C than the wt MeV F, this virus infects and replicates in cotton rat lung tissue more efficiently than the wt virus and is lethal in a suckling mouse model of MeV encephalitis even with a lower inoculum. Thus, either during lethal MeV CNS infection or during antiviral treatment

Identifiants

pubmed: 30728259
pii: JVI.01862-18
doi: 10.1128/JVI.01862-18
pmc: PMC6450100
pii:
doi:

Substances chimiques

Viral Fusion Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI121349
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS091263
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS105699
Pays : United States

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

EMBO J. 1995 Dec 1;14(23):5773-84
pubmed: 8846771
Antiviral Res. 2009 Mar;81(3):261-6
pubmed: 19133295
Lancet. 2012 Jan 14;379(9811):153-64
pubmed: 21855993
Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):2496-2501
pubmed: 29463726
J Virol. 2013 Mar;87(5):2648-59
pubmed: 23255801
J Med Chem. 2006 Aug 24;49(17):5080-92
pubmed: 16913698
J Virol. 2013 Dec;87(24):13785-94
pubmed: 24109233
Virology. 1992 Jun;188(2):910-5
pubmed: 1585658
PLoS Pathog. 2011 Jan 27;7(1):e1001263
pubmed: 21304593
J Virol. 2017 May 12;91(11):
pubmed: 28331086
J Clin Invest. 2008 Jul;118(7):2448-58
pubmed: 18568079
J Neuroimmune Pharmacol. 2010 Sep;5(3):443-55
pubmed: 20419352
Med Microbiol Immunol. 2010 Aug;199(3):261-71
pubmed: 20390298
J Virol. 2013 Jan;87(1):314-26
pubmed: 23077316
Lancet Infect Dis. 2016 Mar;16(3):366-75
pubmed: 26809815
Arch Dis Child. 1993 Jun;68(6):775-8
pubmed: 8333771
J Struct Biol. 1999 Apr-May;125(2-3):156-65
pubmed: 10222271
Nature. 2000 Aug 24;406(6798):893-7
pubmed: 10972291
PLoS One. 2016 Sep 09;11(9):e0162823
pubmed: 27612283
Intern Med. 2006;45(14):841-2
pubmed: 16908939
J Virol. 2011 Jan;85(1):348-56
pubmed: 20980517
Nat Protoc. 2015 Jun;10(6):845-58
pubmed: 25950237
Virus Res. 2005 Aug;111(2):132-47
pubmed: 15893837
J Virol. 2014 Mar;88(5):2951-66
pubmed: 24371057
BMC Bioinformatics. 2006 Aug 16;7:382
pubmed: 16914055
Semin Pediatr Neurol. 2012 Sep;19(3):107-14
pubmed: 22889539
J Virol. 2010 Nov;84(21):11189-99
pubmed: 20719945
Nucleic Acids Res. 1996 Mar 15;24(6):1171-2
pubmed: 8604354
J Virol. 2007 Apr;81(7):3216-28
pubmed: 17229690
J Neuropathol Exp Neurol. 1996 Apr;55(4):471-80
pubmed: 8786407
J Virol. 2015 Mar;89(5):2710-7
pubmed: 25520515
J Virol. 2018 Feb 26;92(6):
pubmed: 29298883
J Virol. 1988 Apr;62(4):1388-97
pubmed: 3346948
mBio. 2015 Feb 10;6(1):
pubmed: 25670774
Biochemistry. 2008 Dec 23;47(51):13573-83
pubmed: 19035834
J Virol. 2013 Mar;87(5):2526-34
pubmed: 23255790
J Virol. 2006 Jul;80(13):6420-9
pubmed: 16775330
PLoS Pathog. 2011 Aug;7(8):e1002240
pubmed: 21901103
Front Immunol. 2014 Sep 16;5:446
pubmed: 25278941
J Virol. 2010 Apr;84(7):3413-20
pubmed: 20071568
Nat Struct Mol Biol. 2008 Jul;15(7):690-8
pubmed: 18596815
Science. 2003 Aug 8;301(5634):804
pubmed: 12907792
J Virol. 2008 Jun;82(11):5359-67
pubmed: 18385234
J Virol. 2015 Jan 15;89(2):1143-55
pubmed: 25378493
MMWR Morb Mortal Wkly Rep. 2015 Nov 13;64(44):1246-51
pubmed: 26562349
Clin Exp Dermatol. 2014 Jan;39(1):117-8
pubmed: 24341480
Virology. 2007 May 25;362(1):235-44
pubmed: 17434199
Curr Opin Investig Drugs. 2009 Aug;10(8):811-20
pubmed: 19649926
Expert Opin Drug Discov. 2014 Feb;9(2):201-14
pubmed: 24303998
Virol J. 2013 Sep 12;10:283
pubmed: 24025157
Nat Chem Biol. 2016 Feb;12(2):87-93
pubmed: 26641933
J Chem Theory Comput. 2017 Jun 13;13(6):3031-3048
pubmed: 28430426
Curr Top Microbiol Immunol. 2009;330:3-30
pubmed: 19203102
PLoS One. 2013 Aug 13;8(8):e71671
pubmed: 23967232
Antimicrob Agents Chemother. 2005 Sep;49(9):3755-61
pubmed: 16127050
S Afr Med J. 2011 May;101(5):313-4, 316-7
pubmed: 21837871
Lancet. 2012 Jun 9;379(9832):2173-8
pubmed: 22534001
J Virol. 2002 Jul;76(13):6743-9
pubmed: 12050387
J Virol. 2017 Nov 14;91(23):
pubmed: 28904193
Lancet Infect Dis. 2018 Oct;18(10):1060-1061
pubmed: 30303095
Viruses. 2012 Apr;4(4):613-36
pubmed: 22590688
Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9288-93
pubmed: 15964978
Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91
pubmed: 8700906
J Clin Virol. 2016 Aug;81:43-6
pubmed: 27315036
Nature. 2011 Nov 02;480(7378):530-3
pubmed: 22048310

Auteurs

Cyrille Mathieu (C)

Center for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA cyrille.mathieu@inserm.fr mp3509@cumc.columbia.edu.
Department of Pediatrics, Columbia University Medical Center, New York, New York, USA.
CIRI, International Center for Infectiology Research, Inserm, U1111, University Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Lyon, France.

Marion Ferren (M)

Center for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA.
Department of Pediatrics, Columbia University Medical Center, New York, New York, USA.
CIRI, International Center for Infectiology Research, Inserm, U1111, University Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Lyon, France.

Eric Jurgens (E)

Center for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA.
Department of Pediatrics, Columbia University Medical Center, New York, New York, USA.

Claire Dumont (C)

CIRI, International Center for Infectiology Research, Inserm, U1111, University Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Lyon, France.

Ksenia Rybkina (K)

Center for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA.
Department of Pediatrics, Columbia University Medical Center, New York, New York, USA.

Olivia Harder (O)

Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, USA.

Debora Stelitano (D)

Center for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA.
Department of Pediatrics, Columbia University Medical Center, New York, New York, USA.

Silvia Madeddu (S)

Center for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA.
Department of Pediatrics, Columbia University Medical Center, New York, New York, USA.
Department of Biomedical Sciences, University of Cagliari, Cittadella Universitaria, Monserrato, Cagliari, Italy.

Giuseppina Sanna (G)

Center for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA.
Department of Pediatrics, Columbia University Medical Center, New York, New York, USA.
Department of Biomedical Sciences, University of Cagliari, Cittadella Universitaria, Monserrato, Cagliari, Italy.

Dayna Schwartz (D)

Center for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA.
Department of Pediatrics, Columbia University Medical Center, New York, New York, USA.

Sudipta Biswas (S)

Center for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA.
Department of Pediatrics, Columbia University Medical Center, New York, New York, USA.

Diana Hardie (D)

Division of Medical Virology, Department of Clinical Laboratory Sciences, University of Cape Town and National Health Laboratory Service, Cape Town, South Africa.

Takao Hashiguchi (T)

Department of Virology, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

Anne Moscona (A)

Center for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA.
Department of Pediatrics, Columbia University Medical Center, New York, New York, USA.
Department of Microbiology and Immunology, Columbia University Medical Center, New York, New York, USA.
Department of Physiology and Cellular Biophysics, Columbia University Medical Center, New York, New York, USA.

Branka Horvat (B)

CIRI, International Center for Infectiology Research, Inserm, U1111, University Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Lyon, France.

Stefan Niewiesk (S)

Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, USA.

Matteo Porotto (M)

Center for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA cyrille.mathieu@inserm.fr mp3509@cumc.columbia.edu.
Department of Pediatrics, Columbia University Medical Center, New York, New York, USA.
Department of Experimental Medicine, University of Study of Campania Luigi Vanvitelli, Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH